Individuals tend to be more affected by vitiligo if it is visible on their face or hands, said David Rosmarin, MD, vice chair of research and education, Department of Dermatology, Tufts Medical Center.
David Rosmarin, MD, vice chair of research and education, Department of Dermatology, Tufts Medical Center, explains how vitiligo can impact a patient's quality of life, and why oral and topical treatment options are important.
Transcript
How does vitiligo affect a patient’s quality of life?
Vitiligo can be very impactful on patients' lives. We know from our research that oftentimes teenagers are very affected by their vitiligo. If patients have involvement of exposed areas such as the face or hands, they often are more affected by their disease. Additionally, if the disease is uncontrolled or progressive and somebody doesn't know when are they going to get another lesion, that also can really affect their quality of life. But every patient is different and some people are not as bothered, and we need to be able to accept everybody who has vitiligo and, for those who want to repigment, hopefully provide them that option.
Do you see a difference in adherence between topical and oral treatments?
It's important to have both an oral option to treat diseases as well as topicals. Orals can be particularly helpful for patients who have a large body surface area, or who find it inconvenient to use topicals, or maybe have progressive or unstable disease, whereas topical treatments are great because you avoid or minimize systemic exposure, and often are great for people who have more localized disease.
An Elevated Member Experience, More Education, and Martha Stewart at the AAD 2025 Annual Meeting
March 4th 2025Seemal R Desai, MD, FAAD, president of the American Academy of Dermatology (AAD), emphasized his commitment to enhancing the upcoming 2025 annual meeting by introducing new events and expanding educational offerings to better serve and engage members.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Redesigning Inpatient Dermatology to Address Costs, Improve Access
February 20th 2025The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to improve care, reduce costs, and address health equity for patients with skin diseases.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More